NEWS
TOPICS
Cancer Vaccines
Clinical Trials
Emerging Markets
Infectious Diseases
Influenza
Manufacturing
Partnering
R&D
Regulatory
Supply Chain
ANALYSIS
Put FiercePharma in your pocket: Download our new mobile app for iOS and Android devices
by Rebecca Friend

FiercePharma news, curated by the crowd
by Tracy Staton

A prosperous new year for pharma? Let's check the tea leaves
by Tracy Staton

Industry Voices

More commentary
FEATURES
Top 5 Vaccine Companies by Revenue - 2012

Top 10 DTC Pharma Advertisers - H1 2013

20 Top-selling Vaccines -- H1 2012

Top 20 orphan drugs by 2018
Top 10 pharma companies by employees

10 promising therapeutic vaccines 2012

Major FDA vaccine approvals of 2012

Top 15 Drug Launch Superstars
LIBRARY
eBooks
Whitepapers
Webinars
View All
EVENTS
Jobs
Marketplace

Tag:

Hoopika

Latest Headlines

Latest Headlines

Hoopika lands $10M for vaccine platform

October 20, 2011 | By Maureen Martino

Austria-based Hoopika has landed $10 million to back development of its platform vaccine technology and fund early-stage trials of the company's lead drug. Sofinnova Partners led the round, with help

THE LIBRARY: WEBINAR

Encapsulation Technologies for Topical Drug Products

| Thursday, May 8th | 2pm ET / 11am PT | Presented by: CPL

In this FastCast webcast we will focus on various encapsulation technologies and manufacturing techniques, and how they may be used to overcome formulation challenges associated with topical products. Register Today!

MORE ITEMS

EVENTS

Drug Development PrimerJune 5-6 — Boston, MA
FierceBiotech Executive Breakfast: Facing the Proof of Concept ChallengeJune 18, 2014 — San Diego, CA — Sponsored by Appian & PRA
Drug Development Boot Camp - November 19-20, 2014, Boston, MANovember 19-20, 2014 — Boston, MA — Hosted by Harvard University OTD and Speid & Associates, Inc.

MORE EVENTS

Press Releases

Financial Results, Upcoming Earnings Schedules, New Launches, and Lawsuit Filings- Analyst Notes on AstraZeneca, Boston Scientific, Valeant, Illumina and Mylan
Amgen To Present At The Deutsche Bank 39th Annual Healthcare Conference
Approvals from the European Commission and Release of Quarterly Financial Results- Analyst Notes on Merck, Johnson & Johnson, Bristol-Myers Squibb, Teva and AbbVie
Amgen To Present At The Deutsche Bank 39th Annual Healthcare Conference
Boehringer Ingelheim and AmeriCares Partner in New Extension of Product Donations Program for the Uninsured
More Press Releases

Featured Jobs

Sponsored Links

A publication ofFierceMarkets

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Click here to get your free weekly email briefing today!

The FierceMarkets Network:

Telecom

FierceCable
FierceDeveloper
FierceWireless:Europe
FierceWirelessTech
FierceOnlineVideo
FierceTelecom
FierceWireless

Marketing & Retail

FierceCMO
FierceRetail
FierceRetailIT
FierceMobileRetail

Healthcare

FierceEMR
FierceHealthcare
FierceHealthFinance
FierceHealthIT
FierceHealthPayer
FierceHealthPayerAntiFraud
FierceMedicalImaging
FierceMobileHealthcare
FiercePracticeManagement
Hospital Impact

Government

FierceGovernment
FierceGovernmentIT
FierceHomelandSecurity
FierceMobileGovernment

Life Sciences

FierceBiotechResearch
FierceBiotech
FierceBiotechIT
FierceCRO
FierceDiagnostics
FierceDrugDelivery
FierceMedicalDevices
FiercePharma
FiercePharmaManufacturing
FiercePharmaMarketing
FierceVaccines

Enterprise IT

FierceBigData
FierceCIO
FierceCIO:TechWatch
FierceContentManagement
FierceEnterpriseCommunications
FierceITSecurity
FierceMobileIT

Energy

FierceEnergy
FierceSmartGrid

Finance

FierceCFO
FierceFinanceIT